Literature DB >> 11937318

Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening.

A B Bos1, M van Ballegooijen, G J van Oortmarssen, J D F Habbema.   

Abstract

Up to 1995, programme screening for cervical cancer in The Netherlands was targeted at women between 35 and 54 years of age at 3-yearly intervals. Spontaneous screening in addition to programme screening was common practice. Our aim was to compare the underlying risk for cervical neoplasia for women involved in both types of screening. From the national pathological database, we retrieved all primary smears (n=693318) taken in 1994 in The Netherlands. Among the smears registered for screening purposes (39%), 79% was taken within the mass screening programme and 21% was taken for spontaneous screening. The underlying risk was studied from the detection rates of histologically confirmed severe dysplasia or worse, using a multivariate loglinear model, including age and screening history. The detection rate of at least severe dysplasia, adjusted for age and screening history, was equal for women who had a spontaneous smear and for those who had a programme smear (odds ratio (OR): 0.97; 95% Confidence Interval (CI): 0.84-1.14). In our data, women participating in spontaneous screening were not at a higher risk for cervical cancer than women who used programme screening. Therefore, all asymptomatic women in the Netherlands should follow the general guidelines for age-range and screening-interval.

Entities:  

Mesh:

Year:  2002        PMID: 11937318     DOI: 10.1016/s0959-8049(02)00026-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  5 in total

1.  The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996.

Authors:  S Bulk; F J Van Kemenade; L Rozendaal; C J L M Meijer
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

2.  Cervical cancer screening in the United States and the Netherlands: a tale of two countries.

Authors:  Dik Habbema; Inge M C M De Kok; Martin L Brown
Journal:  Milbank Q       Date:  2012-03       Impact factor: 4.911

3.  Cytology history preceding cervical cancer diagnosis: a regional analysis of 286 cases.

Authors:  M Gök; L Rozendaal; J Berkhof; O Visser; C J L M Meijer; F J van Kemenade
Journal:  Br J Cancer       Date:  2011-01-25       Impact factor: 7.640

4.  Long-term protective effect of high-risk human papillomavirus testing in population-based cervical screening.

Authors:  N W J Bulkmans; L Rozendaal; F J Voorhorst; P J F Snijders; C J L M Meijer
Journal:  Br J Cancer       Date:  2005-05-09       Impact factor: 7.640

5.  Impact of opportunistic testing in a systematic cervical cancer screening program: a nationwide registry study.

Authors:  Mette Tranberg; Mette Bach Larsen; Ellen M Mikkelsen; Hans Svanholm; Berit Andersen
Journal:  BMC Public Health       Date:  2015-07-21       Impact factor: 3.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.